Atea Pharmaceuticals (AVIR) Return on Sales: 2021
- Atea Pharmaceuticals' Return on Sales was N/A to 0.34% in Q4 2021 from the same period last year, while for Dec 2021 it was 0.34%, marking a year-over-year change of. This contributed to the annual value of 0.34% for FY2021, which is 57.00% up from last year.
- Atea Pharmaceuticals' Return on Sales amounted to 0.34% in Q4 2021.
- Atea Pharmaceuticals' Return on Sales' 5-year high stood at 0.34% during Q4 2021, with a 5-year trough of 0.34% in Q4 2021.
- In the last 1 years, Atea Pharmaceuticals' Return on Sales had a median value of 0.34% in 2021 and averaged 0.34%.